Caribou Biosciences Inc. (CRBU)

1.08

-0.09 (-7.69%)

At close: Mar 03, 2025, 3:59 PM

1.09

0.93%

After-hours: Mar 03, 2025, 06:22 PM EST

Caribou Biosciences Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Net Income	-102.07M	-99.42M	-66.92M	-34.31M	-23.43M
Depreciation & Amortization	3.52M	1.62M	984K	900K	751K
Stock-Based Compensation	13.75M	11.72M	3.45M	1M	1.23M
Other Working Capital	-9.94M	-2.43M	31.13M	-1.07M	-7.84M
Other Non-Cash Items	-1.18M	-584K	2.43M	-1.79M	-2.29M
Deferred Income Tax	n/a	-95K	-1.52M	803K	n/a
Change in Working Capital	-7.32M	-4.2M	29.07M	177K	-8.27M
Operating Cash Flow	-93.29M	-90.97M	-32.52M	-33.22M	-32.01M
Capital Expenditures	-11.61M	-7.05M	-3.12M	-1.31M	-884K
Acquisitions	n/a	600K	n/a	10K	n/a
Purchase of Investments	-394.76M	-339.06M	-173.28M	-10K	n/a
Sales Maturities Of Investments	338.19M	252.87M	n/a	7.67M	28.12M
Other Investing Acitivies	n/a	-600K	-1M	10K	28.12M
Investing Cash Flow	-68.18M	-93.25M	-176.4M	6.36M	27.23M
Debt Repayment	n/a	n/a	1.03M	1.47M	-45K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	1.58M	2.13M	111.38M	270K	217K
Financial Cash Flow	154.3M	2.13M	433.43M	1.74M	172K
Net Cash Flow	-7.18M	-182.08M	224.51M	-25.12M	-4.6M
Free Cash Flow	-104.9M	-98.02M	-35.64M	-34.53M	-32.89M